HBAN
Huntington Bancshares Incorporated
HBAN offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MS
Morgan Stanley
MS has the edge over HBAN overall, supported by stronger fundamentals.
HBAN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| N/A | |
| N/A |
HBAN's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like HBAN.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
HBAN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.3x | $11.20 | -29% |
| Forward | 9.5x | $15.73 | — |
| Fair | 12x | $14.97 | -4.9% |
| Current | 13x | $15.73 | — |
| Expensive | 17x | $19.98 | +27% |
Historical ranges are pointers, not guarantees.
HBAN has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
HBAN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for HBAN, with profitability improving.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
HBAN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.66 | +38% |
| Q3 2026 | $1.21 | -15% |
| Q2 2026 | $1.29 | -3.7% |
| Q1 2026 | $1.30 | 0% |
| Q4 2025 | $1.39 | +14% |
| Q3 2025 | $1.42 | +37% |
| Q2 2025 | $1.34 | +26% |
| Q1 2025 | $1.30 | +17% |
| Q4 2024 | $1.22 | -1.6% |
HBAN earned $1.21 per share over the past year, down 15% from the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over HBAN on earnings, with more consistent year-over-year improvement.
HBAN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.8B | +31% |
| Q2 2026 | $2.8B | +46% |
| Q1 2026 | $2.6B | +34% |
| Q4 2025 | $2.2B | +11% |
| Q3 2025 | $2.1B | +14% |
| Q2 2025 | $1.9B | +7.5% |
| Q1 2025 | $1.9B | +9.5% |
| Q4 2024 | $2B | +14% |
HBAN's revenue has grown year over year for eight quarters in a row: $2.8B last quarter, up 31% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -3.8 points |
| Q2 2026 | 32% | -1.3 points |
| Q1 2026 | 25% | -9.1 points |
| Q4 2025 | 29% | -5.2 points |
| Q3 2025 | 36% | +1.9 points |
| Q2 2025 | 33% | +0.4 points |
| Q1 2025 | 34% | +4.9 points |
| Q4 2024 | 34% | +20 points |
HBAN has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over HBAN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
HBAN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $683M | +53% |
| Q2 2026 | $1B | +105% |
| Q1 2026 | $400M | -13% |
| Q4 2025 | $810M | -44% |
| Q3 2025 | $446M | +$926M |
| Q2 2025 | $500M | +90% |
| Q1 2025 | $459M | +6.3% |
| Q4 2024 | $1.5B | +74% |
HBAN has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
HBAN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -1.4M shares |
| 1 year | +38% | +566M shares |
| 3 years | +40% | +581M shares |
| 5 years | +82% | +922M shares |
| Available history | +94% | +991M shares |
HBAN has 2B diluted shares, up 38% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $100M |
| Q2 2026 | $159M |
| Q1 2026 | $150M |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | $150M |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over HBAN on shareholder dilution, with a more favorable share count trend.
HBAN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.5x | High |
| Q2 2026 | 5.0x | High |
| Q1 2026 | 6.3x | High |
| Q4 2025 | 4.8x | High |
| Q3 2025 | 4.6x | High |
| Q2 2025 | 5.0x | High |
| Q1 2025 | 5.4x | High |
| Q4 2024 | 4.9x | High |
HBAN has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
HBAN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.8 | Neutral |
| Stochastic | 25.1 | Neutral |
HBAN's weekly RSI is 44 (neutral) and its Stochastic is 25 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
HBAN PE vs Financial Services Sector
| Metric | HBAN | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.2% below |
| PE % | 62 | 63 | 1 pt below |
HBAN has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
HBAN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.5 | 1.3% above |
| 20 week MA | $16.6 | 5.2% below |
| 50 week MA | $16.8 | 6.1% below |
| 100 week MA | $16.4 | 4.2% below |
| 200 week MA | $14.7 | 7.2% above |
HBAN's trend is mixed: it's above two of its five weekly moving averages, and 7.2% above its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over HBAN on trend strength, trading above more of its moving averages.
HBAN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.1 | $12.4 | -18% |
| 2021 | $12.4 | $15.3 | +24% |
| 2022 | $15.3 | $14.1 | -7.9% |
| 2023 | $14.1 | $12.7 | -9.5% |
| 2024 | $12.7 | $16.4 | +29% |
| 2025 | $16.4 | $17.7 | +8.3% |
| 2026 YTD | $17.7 | $15.7 | -11% |
HBAN has finished lower in three of the last six years. It's down 11% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over HBAN on returns for 2026, with the stronger performance.